Trialling remote methods of improving patient lives and adapting to systemic autoimmune rheumatic diseases
Not Applicable
- Conditions
- Systemic autoimmune rheumatic diseases (SARDs), Systemic lupus erythematosus (SLE) (lupus)Skin and Connective Tissue Diseases
- Registration Number
- ISRCTN72406488
- Lead Sponsor
- niversity of Cambridge
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 920
Inclusion Criteria
1. Aged 18 years or over
2. Resident in the UK or Ireland
3.1. Phase 1: Have SLE (lupus) as a diagnosis on clinic letters
3.2. Phase 2: Have any Systemic autoimmune rheumatic diseases (SARD) as a diagnosis on clinic letters
Exclusion Criteria
1. Aged under 18 years
2. Not resident in the UK or Ireland.
3. Not having SLE (lupus) for phase 1 or any systemic rheumatic disease for phase 2.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method